These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective. Hogarty GE. J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746 [Abstract] [Full Text] [Related]
7. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia. Schooler NR. J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086 [Abstract] [Full Text] [Related]
9. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature]. Woggon B. Int Pharmacopsychiatry; 1979 Feb; 14(1):34-56. PubMed ID: 39040 [Abstract] [Full Text] [Related]
12. Family management programmes for schizophrenic patients. Prevention of relapse and modification of familial communication patterns. Hahlweg K, Feinstein E, Müller U, Dose M. Br J Psychiatry Suppl; 1989 Jul 26; (5):112-6. PubMed ID: 2574982 [No Abstract] [Full Text] [Related]
13. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients. Glazer WM, Ereshefsky L. J Clin Psychiatry; 1996 Aug 26; 57(8):337-45. PubMed ID: 8752015 [Abstract] [Full Text] [Related]
20. [Treatment and course of schizophrenic psychoses over a decade. Disease course and predictors]. Müller P, Günther U, Lohmeyer J. Nervenarzt; 1986 Jun 01; 57(6):332-41. PubMed ID: 2874507 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]